ArticleEuropean journal of clinical investigation2025

A weekly 4-methylpyrazole treatment attenuates the development of non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) in male mice: Role of JNK.

Katharina Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.